Cargando…

Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis

Growing evidence indicates that dysregulated iron metabolism with altered and excess iron availability in some body compartments plays a significant role in the course of infection and sepsis in humans. Given that all bacterial pathogens require iron for growth, that iron withdrawal is a normal comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehmann, Christian, Aali, Maral, Zhou, Juan, Holbein, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830599/ https://www.ncbi.nlm.nih.gov/pubmed/33466819 http://dx.doi.org/10.3390/life11010057

Ejemplares similares

Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury
por: Lehmann, Christian, et al.
Publicado: (2022)

Iron Chelation as a Potential Therapeutic Approach in Acute Lung Injury
por: Zhang, Xiyang, et al.
Publicado: (2023)

Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative Toxins
por: Fokam, Danielle, et al.
Publicado: (2020)

Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
por: Allan, David S., et al.
Publicado: (2022)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
por: Lehmann, C., et al.
Publicado: (2015)

Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses
por: Ghassemi-Rad, Javad, et al.
Publicado: (2023)

Dysregulated Iron Homeostasis as Common Disease Etiology and Promising Therapeutic Target
por: Holbein, Bruce E., et al.
Publicado: (2023)

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
por: Parquet, Maria del Carmen, et al.
Publicado: (2018)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains
por: Nocera, Francesca Paola, et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Inflammatory Response to Different Toxins in Experimental Sepsis Models
por: Dickson, Kayle, et al.
Publicado: (2019)

Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles’ heel of antibiotic-resistant microbes
por: Holbein, Bruce E., et al.
Publicado: (2021)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
por: Zeng, Xiaoyan, et al.
Publicado: (2021)

Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach
por: Islam, Sufia, et al.
Publicado: (2022)

Bacterial Resistance in Pneumonia in Developing Countries—A Role for Iron Chelation
por: Islam, Sufia, et al.
Publicado: (2019)

Effect of iron chelation on anti-pseudomonal activity of doxycycline
por: Faure, ME, et al.
Publicado: (2021)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Potential Treatment of Retinal Diseases with Iron Chelators
por: Shu, Wanting, et al.
Publicado: (2018)

Iron chelation effect of curcumin and baicalein on aplastic anemia mouse model with iron overload
por: Dijiong, Wu, et al.
Publicado: (2019)

Preventive Therapy of Experimental Colitis with Selected iron Chelators and Anti-oxidants
por: Minaiyan, Mohsen, et al.
Publicado: (2012)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis
por: Khan, Reas S., et al.
Publicado: (2019)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Conformational Stability Effect of Polymeric Iron Chelators
por: Qian, Jian, et al.
Publicado: (2019)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent
Publicado: (1984)

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
por: Nuñez, Marco T., et al.
Publicado: (2018)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
por: Eziefula, Chinea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpd8dj8mj3i9iu5sj7gkas0sah